4-69639480-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001105677.2(UGT2A2):āc.161A>Gā(p.Gln54Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000663 in 1,613,224 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001105677.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UGT2A2 | NM_001105677.2 | c.161A>G | p.Gln54Arg | missense_variant | 1/6 | ENST00000604629.6 | NP_001099147.2 | |
UGT2A1 | NM_001252275.3 | c.716-3658A>G | intron_variant | ENST00000286604.9 | NP_001239204.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UGT2A2 | ENST00000604629.6 | c.161A>G | p.Gln54Arg | missense_variant | 1/6 | 1 | NM_001105677.2 | ENSP00000475028.2 | ||
UGT2A1 | ENST00000286604.9 | c.716-3658A>G | intron_variant | 1 | NM_001252275.3 | ENSP00000286604.4 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152082Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000125 AC: 31AN: 248170Hom.: 1 AF XY: 0.000141 AC XY: 19AN XY: 134632
GnomAD4 exome AF: 0.0000602 AC: 88AN: 1461024Hom.: 2 Cov.: 31 AF XY: 0.0000757 AC XY: 55AN XY: 726748
GnomAD4 genome AF: 0.000125 AC: 19AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74406
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 08, 2024 | The c.161A>G (p.Q54R) alteration is located in exon 1 (coding exon 1) of the UGT2A2 gene. This alteration results from a A to G substitution at nucleotide position 161, causing the glutamine (Q) at amino acid position 54 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at